The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients - Trial NCT06404723
Access comprehensive clinical trial information for NCT06404723 through Pure Global AI's free database. This phase not specified trial is sponsored by Sohag University and is currently Not yet recruiting. The study focuses on Systemic Lupus Erythematosus. Target enrollment is 150 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Fibrinogen to albumin Ratio and C-reactive to Albumin Ratio
Observational
diagnostic test
Sponsor & Location
Sohag University
Timeline & Enrollment
N/A
Jun 01, 2024
Apr 01, 2025
Primary Outcome
Fibrinogen/Albumin ratio, C-reactive protein /Albumin ratio
Summary
The aim of the study was to study the predictive value of FAR and CAR in order to provide a
 new predictive biomarkers for the disease activity and prognosis.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06404723
Non-Device Trial